Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
7m agoWorkday Government Unveils Personnel Action Request (PAR) Agent to Modernize Federal HR and Strengthen Mission Readiness
8m agoCNOOC Limited Achieves Strong Start with Dual Growth in Production and Performance in Q1 2026
9m agoonsemi and Geely Expand Strategic Collaboration to Elevate the Driving Experience
9m agoMyriad Uranium Appoints Eric Miller as Strategic Advisor on US Critical Minerals
42m agoUPDATED NOTICE REGARDING THE PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES ADJOURNMENT OF MEETING OF THE ETP SECURITYHOLDERS
Recursion Pharmaceuticals Inc logo

Recursion Pharmaceuticals Inc

About

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 31 2026
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
Mar 25 2026
Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
Mar 5 2026
PacBio Announces the Appointment of Chris Gibson to the Board of Directors
Feb 25 2026
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Feb 23 2026
Recursion To Be Featured in HighRes’ Lightning Talk at NVIDIA GTC

Financials

Revenue
$74.68 M
Market Cap
$1.64 B
EPS
-1.44

Community Chat

Ask AI

6ix6ix